← FDA DRUG APPROVALS

FDA ANDA · ANDA070505

METOCLOPRAMIDE HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA070505
TYPE
ANDA
ORIGINAL APPROVAL
1989-06-23
LATEST ACTION
1996-10-03
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METOCLOPRAMIDE HYDROCHLORIDEDiscontinued
METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML · INJECTABLE · INJECTION

Approval history

1996-10-03Manufacturing (CMC) · Supplement 5AP
1991-04-19Labeling · Supplement 3AP
1989-06-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →